Natco Pharma Limited has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients.
- Read more about NATCO receives Emergency Use approval for Baricitinib tablets for Covid-19 treatment
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/natco-receives-emergency-use-approval-for-baricitinib-tablets-for-covid-19-treatment
No comments:
Post a Comment